StatLab Medical Products Acquires CellPath Ltd.

Audax Private Equity and Linden Capital Partners Acquire StatLab Medical Products

January 12, 2021

Medical Devices

Audax Private Equity and Linden Capital Partners have acquired StatLab Medical Products, a McKinney, Texas-based manufacturer and distributor of histology, cytology and immunohistochemistry consumables, reagents, and equipment. The deal — a purchase from Cressey & Company LP — positions StatLab for accelerated organic growth and buy-and-build activity to expand its product suite and customer base.

StatLab Medical Products Acquires Pyramid Innovation

August 10, 2021

Medical Devices

StatLab Medical Products, a portfolio company of Audax Private Equity and Linden Capital Partners, has acquired Pyramid Innovation, a Sussex-based developer of pathology slide and cassette printers. The deal expands StatLab’s instrument manufacturing capabilities and strengthens its laboratory automation product lineup while maintaining Pyramid’s operations in Sussex under founder Tom Hughes.

StatLab Acquires Histoserve GmbH and Remaining Stake in Diapath France SAS

August 13, 2025

Medical Devices

StatLab Medical Products completed the acquisitions of Germany-based Histoserve GmbH and the remaining stake in Diapath France SAS, bringing both businesses into the Diapath/StatLab European organization. The transactions expand StatLab’s direct commercial presence across the four largest European pathology markets (France, Germany, Italy and the UK) and strengthen service, distribution and equipment capabilities for pathology laboratories in those markets.

StageBio Acquires TPL Path Labs

October 21, 2020

Healthcare Services

StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.

SourceBio International plc Acquires LDPath Limited

March 29, 2022

Healthcare Services

SourceBio International plc has completed a strategic acquisition of LDPath Limited, a London-based digital pathology testing provider. The deal expands SourceBio's digital and AI-enabled pathology capabilities and creates a larger private provider of cellular and digital pathology services for the U.K. healthcare market.

StatLab Medical Products Acquires Poly Scientific R&D

March 26, 2024

Medical Devices

StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.